Thierry Boon

41.2k citations
266 papers · 35.6k · 10 hit papers · h-index 97

Impact in

  • Immunology top 0.01%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
  • Oncology top 0.1%
    • Cancer Immunotherapy and Biomarkers
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research

Papers in

    • Immunotherapy and Immune Responses 227
    • T-cell and B-cell Immunology 26
    • Immune Cell Function and Interaction 4
    • Cancer Immunotherapy and Biomarkers 10
    • Cutaneous Melanoma Detection and Management 4

Thierry Boon

262 papers receiving 34k citations

Thierry Boon's Hit Papers

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy 2014 · 951 citations
9510+13+27Years since publication5001k1.5k2k2.5k

Peers

Thierry Boon
Comparison fields: 5 of 123
  • Immunology 23.5k
  • Oncology 7.9k
  • Biological Psychiatry 313
  • Molecular Biology 5.7k
  • Genetics 525
Replace Pedro J. Romero with:
Pedro J. Romero Switzerland
Shannon J. Turley United States
Günter Joachim Hämmerling Germany
Licia Rivoltini Italy
Per thor Straten Denmark
Giorgio Parmiani Italy
Laurence A. Turka United States
Esteban Celis United States
Kai W. Wucherpfennig United States
Derin B. Keskin United States
Thierry Boon relative to Pedro J. Romero Switzerland Pedro J. Romero's profile →
Citations per field
00.5×2×4×6×8.0×
Pedro J. Romero · 1×
Citations per year

Countries citing papers authored by Thierry Boon

Since Specialization
Citations

This map shows the geographic impact of Thierry Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Boon more than expected).

Fields of papers citing papers by Thierry Boon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Boon. The network helps show where Thierry Boon may publish in the future.

Co-authors

The 25 scholars most cited alongside Thierry Boon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thierry Boon Line = papers co-authored together Thierry Boon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 266 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
Hit paper breakdown →
19912964
2
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Hit paper breakdown →
20031954
3
Tumor Antigens Recognized by T Lymphocytes
Hit paper breakdown →
19941051
4
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Hit paper breakdown →
2014951
5
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
Hit paper breakdown →
1993823
6
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
Hit paper breakdown →
1994807
7
Human tumor antigens recognized by T lymphocytes.
Hit paper breakdown →
1996725
8 1999685
9
Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor
Hit paper breakdown →
1997682
10 1994679
11
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
Hit paper breakdown →
1992569
12 2005551
13 1994528
14 1999512
15 1995511
16 1995502
17
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice
Hit paper breakdown →
1985476
18 1997462
19 1996452
20
An overview of the MAGE gene family with the identification of all human members of the family.
2001425

About Thierry Boon

Thierry Boon is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Public Health, Environmental and Occupational Health, having authored 266 papers that have together received 35.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (227 papers), T-cell and B-cell Immunology (26 papers), Cancer Immunotherapy and Biomarkers (10 papers), vaccines and immunoinformatics approaches (7 papers), Epigenetics and DNA Methylation (6 papers), Immune Cell Function and Interaction (4 papers), Research on Leishmaniasis Studies (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). The work is most often cited by research in Immunology (23.5k citations), Oncology (7.9k citations), Biological Psychiatry (313 citations), Molecular Biology (5.7k citations) and Genetics (525 citations). Thierry Boon has collaborated with scholars based in Belgium, Switzerland and France. Frequent co-authors include Pierre van der Bruggen, Benoı̂t J. Van den Eynde, Pierre G. Coulie, Etienne De Plaen, Aline Van Pel, Christophe Lurquin, Bernard Lethé, Catia Traversari, Patrick Chomez and Charles De Smet. Their work appears in journals such as International Journal of Cancer, European Journal of Immunology, The Journal of Experimental Medicine, The Journal of Immunology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact